
A whistleblower lawsuit against Questcor Pharmaceuticals, which is now a part of Mallinckrodt, alleges bribes and other fraudulent strategies to boost sales of HP Acthar Gel. The drug, first developed in 1952, is approved for 19 different indications, including multiple sclerosis and arthritis.




























